Literature DB >> 11309492

Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation.

D Conte1, P Liston, J W Wong, K E Wright, R G Korneluk.   

Abstract

The X-linked inhibitor of apoptosis (XIAP) and other members of the inhibitor of apoptosis (IAP) family can suppress apoptosis induced by a diverse variety of triggers. Functional studies done to date have focused on tissue culture models and adenovirus overexpression of XIAP and other IAP proteins. Here we report the phenotype of an engineered transgenic mouse overexpressing a human IAP, as well as assessing the long-term consequence of IAP overexpression. We document the relative protein expression levels of the endogenous mouse homologue to XIAP, mouse inhibitor of apoptosis (MIAP 3), within thymocyte and T cell subpopulations. The consequence of lymphoid-targeted overexpression of XIAP in transgenic mice suggests a physiological role for the endogenous protein, MIAP3. Xiap-transgenic mice accumulated thymocytes and/or T cells in primary and secondary lymphoid tissue, T cell maturation was perturbed, and transgenic thymocytes resisted a variety of apoptotic triggers both in vitro and in vivo. These observations imply a possible key function for the intrinsic cellular inhibitor XIAP in maintaining the homeostasis of the immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309492      PMCID: PMC33161          DOI: 10.1073/pnas.081547998

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Negative selection of lymphocytes.

Authors:  G J Nossal
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 2.  Positive selection of lymphocytes.

Authors:  H von Boehmer
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

3.  Lethal effect of the anti-Fas antibody in mice.

Authors:  J Ogasawara; R Watanabe-Fukunaga; M Adachi; A Matsuzawa; T Kasugai; Y Kitamura; N Itoh; T Suda; S Nagata
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

4.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

5.  Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes.

Authors:  P Liston; N Roy; K Tamai; C Lefebvre; S Baird; G Cherton-Horvat; R Farahani; M McLean; J E Ikeda; A MacKenzie; R G Korneluk
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

6.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

Review 7.  Fas and Fas ligand: lpr and gld mutations.

Authors:  S Nagata; T Suda
Journal:  Immunol Today       Date:  1995-01

8.  Bcl-2 expression promotes B- but not T-lymphoid development in scid mice.

Authors:  A Strasser; A W Harris; L M Corcoran; S Cory
Journal:  Nature       Date:  1994-03-31       Impact factor: 49.962

9.  Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis.

Authors:  A Strasser; A W Harris; D C Huang; P H Krammer; S Cory
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

10.  Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice.

Authors:  D A Grillot; R Merino; G Núñez
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Molecular pharmacodynamics in childhood leukemia.

Authors:  R Pieters; M L den Boer
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

Review 2.  Fas death receptor signalling: roles of Bid and XIAP.

Authors:  T Kaufmann; A Strasser; P J Jost
Journal:  Cell Death Differ       Date:  2011-09-30       Impact factor: 15.828

Review 3.  IAPs: what's in a name?

Authors:  Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Mol Cell       Date:  2008-04-25       Impact factor: 17.970

4.  Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo.

Authors:  Dietrich B Conze; Lori Albert; David A Ferrick; David V Goeddel; Wen-Chen Yeh; Tak Mak; Jonathan D Ashwell
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 5.  Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades.

Authors:  Z Yang; L Song; C Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-12       Impact factor: 3.428

6.  Inhibition of MicroRNA-23b Attenuates Immunosuppression During Late Sepsis Through NIK, TRAF1, and XIAP.

Authors:  Haiju Zhang; Hui Li; Aamir Shaikh; Yi Caudle; Baozhen Yao; Deling Yin
Journal:  J Infect Dis       Date:  2018-06-20       Impact factor: 5.226

7.  Role for X-linked Inhibitor of apoptosis protein upstream of mitochondrial permeabilization.

Authors:  Thomas W Owens; Fiona M Foster; Anthony Valentijn; Andrew P Gilmore; Charles H Streuli
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

8.  XIAP discriminates between type I and type II FAS-induced apoptosis.

Authors:  Philipp J Jost; Stephanie Grabow; Daniel Gray; Mark D McKenzie; Ueli Nachbur; David C S Huang; Philippe Bouillet; Helen E Thomas; Christoph Borner; John Silke; Andreas Strasser; Thomas Kaufmann
Journal:  Nature       Date:  2009-07-22       Impact factor: 49.962

9.  Death pathways in T cell homeostasis and their role in autoimmune diabetes.

Authors:  Matthew A Gronski; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2006-08-10

10.  Regulation of apoptosis by XIAP ubiquitin-ligase activity.

Authors:  Andrew J Schile; María García-Fernández; Hermann Steller
Journal:  Genes Dev       Date:  2008-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.